Position in SLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,426,827
+$4,081,718 QoQ
Shares Held
403,172
+515.7% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 72 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in SLN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. SLN ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in SLN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,426,827 | 403,172 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $345,109 | 65,486 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,973,748 | 324,630 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $6,268,086 | 1,207,724 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,028,194 | 1,211,758 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,640,294 | 2,000,105 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,441,906 | 1,663,068 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $13,115,359 | 721,417 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $5,775,867 | 303,993 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,243,831 | 242,770 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,090,974 | 62,808 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $523,376 | 53,297 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $360,832 | 65,606 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $450,597 | 72,677 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,217,337 | 210,973 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,557,020 | 155,159 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,816,522 | 153,293 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,881,654 | 151,666 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,986,142 | 166,854 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $218,775 | 10,615 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $250,268 | 9,565 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $232,714 | 10,118 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $44,000 | 2,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $34,612 | 2,000 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||